|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||282.26 - 286.00|
|52 Week Range||244.28 - 329.83|
|PE Ratio (TTM)||17.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ionis (IONS) is a biopharmaceutical company that develops and commercializes RNA-targeted therapies.
It's not just Biogen, Teva, and other drugmakers. It's the entire system.
Key highlights include regulatory approvals for companies like Alexion (ALXN) and Ironwood while Biogen is one of the companies facing an investigation into the pricing of multiple sclerosis drugs.